Raymond James Financial Services Advisors, Inc. Biocryst Pharmaceuticals Inc Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$9.5 - $17.24 $150,299 - $272,754	-15,821 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$7.37 - $13.61 $116,600 - $215,323	15,821 New	15,821 $161,000
Q4 2020 Feb 12, 2021	SELL	$3.37 - $8.61 $42,809 - $109,372	-12,703 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$3.43 - $5.53 $43,571 - $70,247	12,703 New	12,703 $44,000
Q1 2019 May 06, 2019	SELL	$7.38 - $9.72 $211,828 - $278,993	-28,703 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$6.51 - $9.6 $186,856 - $275,548	28,703 New	28,703 $232,000

Others Institutions Holding BCRX

# of Institutions

279

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

Vanguard Group Inc Valley Forge, PA

20.3M
Shares

$154 Million
0.0% of portfolio
Black Rock Inc. New York, NY

20M
Shares

$152 Million
0.0% of portfolio
Avoro Capital Advisors LLC New York, NY

11.9M
Shares

$90.2 Million
1.36% of portfolio
Kynam Capital Management, LP Princeton, NJ

9.09M
Shares

$69 Million
5.66% of portfolio
State Street Corp Boston, MA

8.85M
Shares

$67.3 Million
0.0% of portfolio

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account